In terms of the tissue immunoexpression of BK receptors and their cleaved forms, the COVID-19 group had a significant increase in B1R (p < 0.0001) and B2R tissue expression (p < 0.0001) compared with the CONTROL group. This evidence concerns the gene BDKRB2 and COVID-19.